Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

U.S. weight-loss stock concepts rose, with Eli Lilly climbing more than 4% to hit a record high, Amgen up over 3%, and Novo Nordisk and Pfizer each up more than 1%.

07/01/2026 06:45 UTC
Share
Complaint Report
U.S. weight-loss stock concepts rose, with Eli Lilly climbing more than 4% to hit a record high, Amgen up over 3%, and Novo Nordisk and Pfizer each up more than 1%.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
i
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.